Research progress of natural products in the treatment of hepatic fibrosis by regulating TGF-β1/Smad pathway
DOI:
CSTR:
Author:
Affiliation:

Guizhou University of Traditional Chinese Medicine,Guiyang

Clc Number:

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    TGF-β1 is considered to be a key mediator in the formation of hepatic fibrosis, mainly by activating its downstream Smad signaling pathway. Smad2 and Smad3 are two major downstream regulators that promote TGF-β1-mediated tissue fibrosis, while Smad7 is a negative feedback regulator of the TGF-β1/Smad pathway and inhibits TGF-β1-mediated hepatic fibrosis. A growing number of studies have shown that natural products can delay the progression of HF by regulating the TGF-β1/Smad pathway, inhibiting HSC activation and reducing ECM deposition. This article reviews the molecular mechanism of TGF-β1/Smad signaling pathway in hepatic fibrosis, and summarizes the natural products that target the regulation of TGF-β1/Smad signaling pathway, in order to provide reference for the treatment of hepatic fibrosis.

    Reference
    Related
    Cited by
Get Citation
Related Videos

Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:February 28,2024
  • Revised:May 13,2024
  • Adopted:October 16,2024
  • Online:
  • Published:
Article QR Code